Autoimmune hepatitis in association with ramelteon

Area of Science:

• Pharmacology
• Immunology
• Hepatology

Background:

• Ramelteon is a selective melatonin receptor agonist used for insomnia.
• Unlike traditional hypnotics, ramelteon has low abuse potential and minimal residual effects.
• Melatonin receptors (MT1 and MT2) are present in various tissues, including immune cells.

Observation:

• A 50-year-old man developed autoimmune hepatitis after initiating ramelteon treatment for insomnia.
• The patient's condition emerged with a clear temporal relationship to ramelteon's introduction.
• No other confounding factors were identified as the primary cause.

Findings:

• Melatonin and its agonists can modulate immune system function.
• Immune cells express melatonin receptors, suggesting direct influence.
• Ramelteon's mechanism as a melatonin agonist may potentiate autoimmune responses.

Implications:

• Ramelteon's immunomodulatory properties may contribute to the development of autoimmune diseases like hepatitis.
• Further research is warranted to explore the link between melatonin agonists and autoimmunity.
• Clinicians should consider potential immune-related side effects when prescribing ramelteon.